Friday 27 May 2016

NICE News May 2016


New guidance and standards

Treating jaundice in newborn babies

NICE has updated guidelines on diagnosing and treating neonatal jaundice. Jaundice affects approximately 60% of term and 80% of preterm babies in their first week of life. While early and prolonged jaundice is usually harmless, sometimes it is an indication of serious liver disease. New recommendations cover measuring and monitoring bilirubin levels, and the type of phototherapy to use.
Read more

NICE recommends three treatments for type 2 diabetes

Tens of thousands of people with type 2 diabetes will be eligible for new treatments under new guidance from NICE. The drugs will help to control blood sugar in those patients who cannot take more commonly prescribed medicines meaning their condition remains stable for longer. An estimated 31,000 people may be eligible for the three recommended treatments: canagliflozin (Invokana), dapagliflozin (Forxiga) and empagliflozin (Jardiance).
Read more

News
Antimicrobial resistance: A call to action

Antibiotic resistance could kill ten million people a year by 2050, a stark government report has warned. Lord Jim O’Neill, former chairman of Goldman Sachs has set out his final report on the global challenge of resistance to commonly used drugs. NICE guidance on antimicrobial stewardship highlights the importance for healthcare professionals to only prescribe antibiotics when they are needed. Doctors need to give the right antibiotic, at the right dose to the right patient.
Read more

In the bag - improving the move between hospitals and care homes

The introduction of a 'red bag' Hospital Transfer Pathway has helped to improve and speed up the transfer between hospital and care home settings. Sutton Homes of Care Vanguard Programme developed the simple and novel approach to follow NICE guidance on the transition between hospital and care home settings.
Read more

Action is needed to address inequalities in end of life care

Failure to recognise individuals’ needs means patients are receiving poor quality end of life care, a highly critical report by the Care Quality Commission has found. NICE guidance on end of life care highlights the need for healthcare professionals to recognise when a person is entering their final days of life. The recommendations aim to support medical and social care staff so that they can provide their patients with care that is tailored to their needs and desires.
Read more

Features
Catch up on our dual diagnosis Twitter chat

Earlier this month mental health expert Professor Alan Maryon-Davis, took over the NICE Twitter account to discuss our draft recommendation on severe mental illness and substance misuse. Have a look at the conversation.
Read more

Have your say

Comment on our children's attachment quality standard

Comment on our draft quality standard on children’s attachment. The quality standard will cover the identification, assessment and treatment of attachment difficulties in children and young people up to age 18 who are:
  • adopted from care
  • in special guardianship
  • looked after by local authorities in foster homes (including kinship foster care)
  • in residential units and other accommodation
  • or on the edge of care.
Please submit any comments to QSconsultations@nice.org.uk by Tuesday 21 June.
Read more

Get involved 

Expert advisers needed to help us develop clinical guidelines

We’re looking for topic experts to help us develop our clinical guidelines. In particular, we’re seeking to recruit:
  • medical microbiologist (with responsibilities around infection control)
  • infection control clinician
  • registered paramedic
  • nursing professionals and practice leads with an interest in infection control in primary, community and tertiary care
  • vascular specialist podiatrist.
The closing date for applications is 5pm on Friday 17 June 2016.
Apply now

Lay members required to help develop dementia guidelines

We’re looking for lay members to join the social care subgroup for the dementia guidelines committee. In particular we’re seeking people with an understanding of social care for people with dementia and the issues important to people using services and their unpaid carers.

The closing date for applications is 11.59 pm on Sunday 12 June 2016.
Apply now

Into practice 

Using telehealth to improve care

Patients with atrial fibrillation and heart valve disease who self-monitored their coagulation status has led to reduced time attending clinics and cost savings. By giving patients self-monitoring coagulation meters, County Durham and Darlington NHS Foundation Trust used telehealth to address capacity issues across the trust.
Read more

Giving every child the best start to life - Public Health Matters

Public Health England has produced guidance to increase the proportion of children ready to learn at 2 and ready for school at 5. The guidance includes a number of recommendations from NICE on topics such as immunisation, domestic violence, and postnatal depression.
Read more

No time for Cochrane Reviews

Cochrane Clinical Answers now make it easier to use Cochrane Reviews to inform healthcare decisions.

Funded by NICE, and provided by Cochrane Library, this new service for healthcare practitioners, including junior doctors and senior consultants, provides practical evidence designed to inform decision making at the point of care.

Based on the high-quality evidence of Cochrance systematic reviews, Cochrane Clinical Answers covers 32 clinical specialties. Each Cochrane Clinical Answer is displayed in a user friendly question and answer format. There are outcome-focused presentations of the impact of interventions on the patient and the ability to ‘drill down’ to the evidence from the Cochrane Review.

Go to Cochrane Clinical Answers or search other high quality specialist resources via NICE Evidence Resources.
 
Read more

Thursday 19 May 2016

Looking for resources for Revalidation?



Click here to view the Library's reading list of Revalidation resources available to borrow from the RSCH Library.


Friday 13 May 2016

NICE Eyes on Evidence - Issue 84 May 2016


This month's Eyes on Evidence includes:

Surgery versus medical therapy in ulcerative colitis
A retrospective cohort study using US data found that elective colectomy was associated with better survival than long-term medical therapy in people with advanced ulcerative colitis, in particular in people aged 50 years or older.

Self-monitoring for people on vitamin K anatagonist anticoagulant therapy
A meta-analysis found that for people receiving long-term vitamin K antagonist therapy, self-monitoring of anticoagulation status with point-of-care devices was at least as safe as monitoring by healthcare professionals.

Shared decision-making: antibiotic use for acute respiratory infections
A Cochrane review found moderate quality evidence that interventions to facilitate shared decision-making reduced antibiotic prescribing for acute respiratory infections in primary care in the short term.

Previous pregnancies in young women having an abortion
A retrospective cohort study of data from England and Wales found that nearly 1 in 4 women aged less than 20 years who underwent an abortion had already had at least 1 previous birth or abortion. Post-abortion contraceptive counselling should take a ‘woman-centred’ approach that focuses on women’s contraceptive preferences.

Mental health of carers after bereavement
A case–control study in Northern Ireland found that people who had cared for someone with a long-term condition who died subsequently had poor mental health after bereavement, but mental health was similarly poor in carers who had not been bereaved.

Evidence summaries from NICE's Medicines and Prescribing Programme
NICE has recently published summaries on:
  • Chronic wounds: advanced wound dressings and antimicrobial dressings
  • Moderate to severe acute post-operative pain: sufentanil sublingual tablet system
  • Attention deficit hyperactivity disorder in children and young people: guanfacine prolonged-release
  • Adverse events associated with off-label medicine use in adults
  • Myocardial infarction: risks and benefits of extended dual antiplatelet therapy